Statistical inference for tumor growth inhibition T/C ratio (Q36344897)

13 August 2017

Statistical inference for tumor growth inhibition T/C ratio (English)

1 reference

13 August 2017

1 reference

Jianrong Wu

1

1 reference

13 August 2017

1 September 2010

1 reference

Journal of Biopharmaceutical Statistics

13 August 2017

1 reference

13 August 2017

20

1 reference

13 August 2017

5

1 reference

13 August 2017

954-964

1 reference

Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668933

Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668933

Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668933

Small-sample inference for incomplete longitudinal data with truncation and censoring in tumor xenograft models

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668933

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668933

Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668933

Statistical analysis of in vivo tumor growth experiments

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668933

The pediatric preclinical testing program: description of models and early testing results.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668933

Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4668933

Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue

22 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20721784

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Likelihood analysis for the ratio of means of two independent log-normal distributions

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20721784

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1080/10543401003618983

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

PMCID

4668933